Antitumor effects of analogs of hypothalamic hormones in endocrine-dependent cancers (41797)

Andrew V Schally, A. M. Comaru-Schally, T. W. Redding

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

A new approach to the treatment of endocrine-dependent tumors based on analogs of hypothalamic hormones is in the early stages of development, but appears promising and significant. Administration of hypothalamic hormones can mimic hypophysectomy and gonadectomy, and is essentially devoid of side effects. A successful use of agonistic analogs of LH-RH for treatment of endocrine-dependent prostate cancer has been documented in several hundred patients. Experimental studies suggest that agonists and/or antagonists of LH-RH might be useful for treatment of breast cancer and pituitary tumors. Our work in animal models also indicates that analogs of somatostatin, alone or combined with LH-RH agonists, could be considered for therapy of chondrosarcomas, osteosarcomas, and pancreatic cancer. Experiments are in progress on the use of LH-RH analogs for treatment of ovarian cancer, neoplasms of the female genital tract, and for protection against gonadal damage during chemotherapy. These investigations should extend the concepts of endocrine treatment of cancers.

Original languageEnglish
Pages (from-to)259-281
Number of pages23
JournalProceedings of the Society for Experimental Biology and Medicine
Volume175
Issue number3
StatePublished - Dec 1 1984
Externally publishedYes

Fingerprint

Endocrine Gland Neoplasms
Hypothalamic Hormones
Gonadotropin-Releasing Hormone
Tumors
Pituitary Neoplasms
Ovarian Neoplasms
Chemotherapy
Therapeutics
Somatostatin
Breast Neoplasms
Hypophysectomy
Chondrosarcoma
Animals
Osteosarcoma
Pancreatic Neoplasms
Prostatic Neoplasms
Animal Models
Drug Therapy
Experiments

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Antitumor effects of analogs of hypothalamic hormones in endocrine-dependent cancers (41797). / Schally, Andrew V; Comaru-Schally, A. M.; Redding, T. W.

In: Proceedings of the Society for Experimental Biology and Medicine, Vol. 175, No. 3, 01.12.1984, p. 259-281.

Research output: Contribution to journalArticle

@article{d7a8c267d0a14bc9a2a5d16ff7441b28,
title = "Antitumor effects of analogs of hypothalamic hormones in endocrine-dependent cancers (41797)",
abstract = "A new approach to the treatment of endocrine-dependent tumors based on analogs of hypothalamic hormones is in the early stages of development, but appears promising and significant. Administration of hypothalamic hormones can mimic hypophysectomy and gonadectomy, and is essentially devoid of side effects. A successful use of agonistic analogs of LH-RH for treatment of endocrine-dependent prostate cancer has been documented in several hundred patients. Experimental studies suggest that agonists and/or antagonists of LH-RH might be useful for treatment of breast cancer and pituitary tumors. Our work in animal models also indicates that analogs of somatostatin, alone or combined with LH-RH agonists, could be considered for therapy of chondrosarcomas, osteosarcomas, and pancreatic cancer. Experiments are in progress on the use of LH-RH analogs for treatment of ovarian cancer, neoplasms of the female genital tract, and for protection against gonadal damage during chemotherapy. These investigations should extend the concepts of endocrine treatment of cancers.",
author = "Schally, {Andrew V} and Comaru-Schally, {A. M.} and Redding, {T. W.}",
year = "1984",
month = "12",
day = "1",
language = "English",
volume = "175",
pages = "259--281",
journal = "Experimental Biology and Medicine",
issn = "0037-9727",
publisher = "Society for Experimental Biology and Medicine",
number = "3",

}

TY - JOUR

T1 - Antitumor effects of analogs of hypothalamic hormones in endocrine-dependent cancers (41797)

AU - Schally, Andrew V

AU - Comaru-Schally, A. M.

AU - Redding, T. W.

PY - 1984/12/1

Y1 - 1984/12/1

N2 - A new approach to the treatment of endocrine-dependent tumors based on analogs of hypothalamic hormones is in the early stages of development, but appears promising and significant. Administration of hypothalamic hormones can mimic hypophysectomy and gonadectomy, and is essentially devoid of side effects. A successful use of agonistic analogs of LH-RH for treatment of endocrine-dependent prostate cancer has been documented in several hundred patients. Experimental studies suggest that agonists and/or antagonists of LH-RH might be useful for treatment of breast cancer and pituitary tumors. Our work in animal models also indicates that analogs of somatostatin, alone or combined with LH-RH agonists, could be considered for therapy of chondrosarcomas, osteosarcomas, and pancreatic cancer. Experiments are in progress on the use of LH-RH analogs for treatment of ovarian cancer, neoplasms of the female genital tract, and for protection against gonadal damage during chemotherapy. These investigations should extend the concepts of endocrine treatment of cancers.

AB - A new approach to the treatment of endocrine-dependent tumors based on analogs of hypothalamic hormones is in the early stages of development, but appears promising and significant. Administration of hypothalamic hormones can mimic hypophysectomy and gonadectomy, and is essentially devoid of side effects. A successful use of agonistic analogs of LH-RH for treatment of endocrine-dependent prostate cancer has been documented in several hundred patients. Experimental studies suggest that agonists and/or antagonists of LH-RH might be useful for treatment of breast cancer and pituitary tumors. Our work in animal models also indicates that analogs of somatostatin, alone or combined with LH-RH agonists, could be considered for therapy of chondrosarcomas, osteosarcomas, and pancreatic cancer. Experiments are in progress on the use of LH-RH analogs for treatment of ovarian cancer, neoplasms of the female genital tract, and for protection against gonadal damage during chemotherapy. These investigations should extend the concepts of endocrine treatment of cancers.

UR - http://www.scopus.com/inward/record.url?scp=0021636524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021636524&partnerID=8YFLogxK

M3 - Article

C2 - 6141569

AN - SCOPUS:0021636524

VL - 175

SP - 259

EP - 281

JO - Experimental Biology and Medicine

JF - Experimental Biology and Medicine

SN - 0037-9727

IS - 3

ER -